Market Value369,526,506
Total Holdings48
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BBIO / BridgeBio Pharma, Inc.
VXRT / Vaxart, Inc.
LH / Labcorp Holdings Inc.
STOK / Stoke Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
ABT / Abbott Laboratories
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
HUMA / Humacyte, Inc.
XFOR / X4 Pharmaceuticals, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
VSTM / Verastem, Inc.
GMED / Globus Medical, Inc.
RVNC / Revance Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
OCUL / Ocular Therapeutix, Inc.
LH / Labcorp Holdings Inc.
MDT / Medtronic plc
VINC / Vincerx Pharma, Inc.
SNN / Smith & Nephew plc - Depositary Receipt (Common Stock)
ARQT / Arcutis Biotherapeutics, Inc.
PRLD / Prelude Therapeutics Incorporated
THRD / Third Harmonic Bio, Inc.
APGE / Apogee Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
EMBC / Embecta Corp.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
CRBP / Corbus Pharmaceuticals Holdings, Inc.
OGN / Organon & Co.
IART / Integra LifeSciences Holdings Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
HCSG / Healthcare Services Group, Inc.
CTMX / CytomX Therapeutics, Inc.
FUSN / Fusion Pharmaceuticals Inc.
IRWD / Ironwood Pharmaceuticals, Inc. Put
IRWD / Ironwood Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc. Put
SPRY / ARS Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
BDSX / Biodesix, Inc.
AVTX / Avalo Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
NYXH / Nyxoah SA
GSK / GSK plc - Depositary Receipt (Common Stock)
ANIP / ANI Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc.
HUMAW / Humacyte, Inc. - Equity Warrant
TYRA / Tyra Biosciences, Inc.
KVUE / Kenvue Inc.
VTYX / Ventyx Biosciences, Inc.
TFX / Teleflex Incorporated
APRE / Aprea Therapeutics, Inc.
ERAS / Erasca, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
IDYA / IDEAYA Biosciences, Inc.
BLCO / Bausch + Lomb Corporation
CI / The Cigna Group
ZBH / Zimmer Biomet Holdings, Inc.
IRON / Disc Medicine, Inc.
INSM / Insmed Incorporated Put
CNTX / Context Therapeutics Inc.
NXTC / NextCure, Inc.
MODD / Modular Medical, Inc.
FHTX / Foghorn Therapeutics Inc.